Prevention of Early Ventilator-Associated Pneumonia after Cardiac ArrestBruno François, Amélie Le Gouge, Alain Cariou et al.|New England Journal of Medicine|2019Cited by 185
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosaBruno François, Jean Chastre, Charles‐Édouard Luyt et al.|Critical Care Medicine|2012Cited by 182
Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of IllnessJean-Baptiste Lascarrou, J L Dubois-Randé, Daniel Jost et al.|CHEST Journal|2022Cited by 27
EPIDEMIOLOGICAL CHARACTERISTICS AND SEVERITY OF OMICRON VARIANT CASES IN THE APHP CRITICAL CARE UNITSAntoine Vieillard‐Baron, Brice Lortat‐Jacob, Rémi Flicoteaux et al.|medRxiv|2022Cited by 12